To confirm the significant role of p21 in the efficacy of BI-2536/fasudil, we silenced p21 expression by RNAi and the CRISPR/CAS9 system, and analysed its effects on the cell cycle progression in KRAS-mutant cancer cells. This evidence concerns the gene CDKN1A and cancer.